CJC-1295 DAC 5mg – High-Purity Research Peptide
CJC-1295 With DAC 5mg Peptide is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH) developed for research into long-acting peptide systems and endocrine signalling pathways. The addition of a Drug Affinity Complex (DAC) is designed to extend the compound’s circulation time through albumin binding.
Bluewell Peptides lists this product at greater than 99.1% purity by HPLC, with a batch-specific Certificate of Analysis (COA) available for reviewing reported analytical results and product traceability.
Researchers should consult the relevant batch documentation and validated laboratory procedures before use.
What Is CJC-1295 DAC?
Its DAC modification enables albumin binding, a design feature intended to prolong circulation compared with shorter-acting peptide analogues.
In laboratory settings, CJC-1295 DAC may serve as a model compound for examining peptide stability, exposure duration, receptor-related pathways, and time-dependent signalling. Research findings depend on the experimental model, study design, and analytical methods used.
CJC-1295 DAC 5mg – Product Specifications
| Specification | Details |
|---|---|
| Product name | CJC-1295 DAC 5mg |
| Catalogue number | BWP-CJC-DAC5 |
| CAS number | 446262-90-4 — verify against supplier documentation |
| Molecular formula | Confirm against the batch-specific technical documentation |
| Molecular weight | Confirm against the batch-specific technical documentation |
| Physical form | Lyophilised solid |
| Reported purity | Greater than 99.1% by HPLC, as stated by the supplier |
| Unit size | 5mg |
| Storage | Follow the product label and applicable stability documentation |
Documentation note: Confirm the CAS number, molecular formula, and molecular weight against a reliable reference and the supplier’s current technical records before publication. These identifiers should not be treated as independently verified solely because they appear in a product listing.
Laboratory Handling and Storage
CJC-1295 DAC is supplied in lyophilised form. Appropriate handling depends on the material’s documented stability, the requirements of the experiment, and the laboratory’s validated procedures.
- Storage: Follow the supplier’s specified storage conditions and temperature guidance.
- Light protection: Protect the material from light when required by its handling documentation.
- Laboratory procedures: Use appropriate laboratory controls and validated methods for handling and analysis.
- Solvents and sample preparation: Select methods according to the analytical objective, solvent compatibility, and approved laboratory protocol.
- Batch traceability: Retain the product label, batch number, and associated Certificate of Analysis for research records.
This product is not presented for human or veterinary administration. No human-use dosage or administration instructions are provided.
Research Applications of CJC-1295 DAC
CJC-1295 DAC is relevant to several areas of peptide research, including:
1. Growth Hormone Signalling Research
Investigated in experimental models examining GHRH-related pathways and the regulation of growth hormone secretion.
2. Peptide Pharmacokinetics
Studied as an example of a peptide designed for prolonged circulation, including research into exposure duration and elimination characteristics.
3. Endocrine Pathway Studies
May be relevant to laboratory investigations of endocrine signalling and related biological mechanisms. Specific conclusions must be based on suitable experimental evidence.
4. Sustained-Exposure Models
The DAC modification makes the compound relevant to research exploring albumin binding and approaches to extending peptide circulation time.
Research applications should be supported by appropriate scientific literature. Preclinical findings do not establish safety, efficacy, or suitability for human use.
Why Choose CJC-1295 DAC 5mg from Bluewell Peptides?
Bluewell Peptides lists CJC-1295 DAC 5mg for laboratory research, with product information intended to support informed purchasing and batch traceability.
- Defined product size: Supplied as a 5mg unit.
- Research-focused product information: Specifications and handling considerations help researchers assess the material for their intended laboratory work.
- Supplier support: Contact Bluewell Peptides for current documentation, availability, shipping information, and product-specific enquiries.
Purity, identity, and quality are distinct analytical considerations.
Frequently Asked Questions
What is CJC-1295 DAC 5mg?
What does DAC mean?
DAC stands for Drug Affinity Complex.
What purity does Bluewell Peptides report?
The product listing states greater than 99.1% purity by HPLC. Review the relevant COA to confirm the reported result and understand the scope of the analysis.
Is a Certificate of Analysis available?
Bluewell Peptides states that a COA is available with each batch. Confirm that the document corresponds to the batch supplied and review its analytical details.
Follow the storage conditions specified on the current product label and supporting technical documentation.
Conclusion
CJC-1295 DAC 5mg is a research peptide relevant to studies of GHRH-related signalling, albumin binding, and extended peptide circulation. Its DAC modification distinguishes it from shorter-acting peptide research models, making it a subject of interest in pharmacokinetic and endocrine-pathway investigations.
Bluewell Peptides lists the product with greater than 99.1% HPLC-reported purity and batch-specific COA documentation. Researchers should review the available analytical records, confirm technical identifiers, and follow appropriate laboratory handling procedures before using the material in an experiment.
Legal and Safety Information
All handling and research activities must comply with applicable laws, regulations, and institutional requirements.
